Summary
Overview
Work History
Education
Skills
Languages
Publications
Personal Information
Research
Affiliations
Timeline
Generic
Pratik Mallick

Pratik Mallick

Munich

Summary

Motivated PhD researcher studying viral pathogenesis and viral immunobiology, focusing on Hepatitis B and SARS-CoV-2 viruses. Major area of research include circular RNAs and CRISPR based genome editing.

Overview

4
4
years of professional experience

Work History

PhD Researcher

Technical University of Munich
01.2022 - Current

Conducting research on: Designing novel RNA based therapeutics against chronic Hepatitis B infection infection

  • My PhD research focuses on developing novel therapeutic strategies for chronic HBV infection. I am working on three key approaches: designing a therapeutic circRNA vaccine to enhance antiviral immunity, using CRISPR-based Base and Prime Editors to inactivate HBV cccDNA, and investigating the role of M6A-modified circRNAs in HBV pathogenesis. Together, these studies aim to advance our understanding of HBV and contribute to innovative antiviral therapies
  • Techniques used: [e.g., Molecular cloning, artificial RNA synthesis and purification, protein expression analysis, CRISPR based screening, mammalian cell culture]

Research Assistant

National Institute of Cholera and Enteric Diseases
06.2021 - 09.2022
  • continued working with the drug to determine its role in pre and post treatment during rotavirus infection
  • studying post translational modifications that occur during rotavirus infection in-vitro
  • learnt the process of sequencing stool samples, submitted to Beleghata I.D. Hospital, showing positive enteric virus infection (Rotavirus, Norovirus, Astrovirus and Adenovirus)
  • worked on some computation studies on SARS-CoV-2 infection

Master's Thesis

National Institute of Cholera and Enteric Diseases
02.2021 - 06.2021

• worked under Dr. Mamta Chawla Sarkar at Virology Division of ICMR- National Institute of Cholera and Enteric Diseases, Kolkata for dissertation project on “Repurposing anthelmintic drug, Niclosamide to combat Rotavirus Infection in-vitro”from February,2021 till May,2021.

  • Techniques used: (ELISA, Western Blotting, Confocal Microscopy, Mammalian cell culture)

Education

PhD - Medical Life Science and Technology

Institute of Virology, Technical University of Munich
02.2025

Integrated MSc - Biotechnology

St. Xavier's College (Autonomous)
01.2021

Skills

  • Molecular Biology
  • ELISA
  • Western and Southern Blot Analysis
  • Flow Cytometry
  • qRT-PCR and Digital PCR
  • Confocal Microscopy
  • Fluorescence Microscopy
  • Mammalian cell culture
  • Data Analysis

Languages

English
Bengali
Hindi
German (learning)

Publications

Emergence of a Novel SARS-CoV-2 Pango Lineage B.1.1.526 in West Bengal, India, Sarkar R, Saha R, Mallick P, Sharma R, Kaur A, Dutta S, Chawla-Sarkar M, Journal of Infection and Public Health, 2021, https://doi.org/10.1016/j.jiph.2021.11.020

Personal Information

  • Date of Birth: 12/15/97
  • Nationality: Indian

Research

PhD Researcher, 08/01/22, Present, Technical University of Munich/Institute of Virology, Conducting research on: Designing novel RNA based therapeutics against chronic Hepatitis B infection., Developing novel therapeutic strategies for chronic HBV infection., Working on three key approaches: designing a therapeutic circRNA vaccine, using CRISPR-based Base and Prime Editors, and investigating the role of M6A-modified circRNAs in HBV pathogenesis.

Affiliations

  • Institute of Virology, Technical University of Munich, Germany

Timeline

PhD Researcher

Technical University of Munich
01.2022 - Current

Research Assistant

National Institute of Cholera and Enteric Diseases
06.2021 - 09.2022

Master's Thesis

National Institute of Cholera and Enteric Diseases
02.2021 - 06.2021

Integrated MSc - Biotechnology

St. Xavier's College (Autonomous)

PhD - Medical Life Science and Technology

Institute of Virology, Technical University of Munich
Pratik Mallick